Article
Structural and biochemical properties of L‐asparaginase
1 Jun 2021
Abstract excerpt
l-Asparaginase (a hydrolase converting l-asparagine to l-aspartic acid) was the first enzyme to be used in clinical practice as an anticancer agent after its approval in 1978 as a component of a treatment protocol for childhood acute lymphoblastic leukemia. Structural and biochemical properties of l-asparaginases have been extensively investigated during the last half-century, providing an accurate structural...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
